Erratum: Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study

Autor:	Arthur Kavanaugh, Iain McInnes, Philip Mease, Gerald G. Krueger, Dafna Gladman, Juan Gomez-Reino, Kim Papp, Julie Zrubek, Surekha Mudivarthy, Michael Mack, Sudha Visvanathan, Anna Beutler
Rok vydání:	2010
Předmět:	Rheumatology Immunology Immunology and Allergy Pharmacology (medical)
Zdroj:	Arthritis & Rheumatism. 62:2555-2555
ISSN:	0004-3591
DOI:	10.1002/art.27673
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3aef901a3b3ed2b7594e711daecfe6e1 https://doi.org/10.1002/art.27673 Zobrazit plný text záznamu Plný text